Compositions and methods for the use of bcl-2 transfected neurons
CA 2488744 A1 · Owner: Wang, Shu · Inventors: Wang, Shu; Haglid, Kenneth
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The use of Bcl-2 transfected neurons and/or stem cells for the production of a pharmaceutical preparation for in vivo treatment of neurological conditions such as Parkinson's disease is disclosed. Also disclosed is a method for treatment of neurological conditions, wherein Bcl-2 transfected neurons are transplanted to a patient.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 5, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 5, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 5, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.